000			04410nam a22007097a 4500
008			220124s20212021 xxu||||| |||| 00| 0 eng d
022			_a1051-0443
024			_a10.1016/j.jvir.2021.10.017 [doi]
024			_aS1051-0443(21)01444-5 [pii]
040			_aOvid MEDLINE(R)
099			_a34718097
245			_aProspective Study of Radial Artery Occlusion Following Transradial Arterial Access during IR Procedures.
251			_aJournal of Vascular & Interventional Radiology. 33(2):130-135, 2022 02.
252			_aJ Vasc Interv Radiol. 33(2):130-135, 2022 02.
252			_zJ Vasc Interv Radiol. 2021 Oct 27
253			_aJournal of vascular and interventional radiology : JVIR
260			_c2022
260			_fFY2022
260			_p2021 Oct 27
265			_sppublish
266			_d2022-01-25
268			_aJournal of Vascular & Interventional Radiology. 2021 Oct 27
501			_aAvailable online through MWHC library: 2002 - 2006, Available in print through MWHC library: 1999 - 2006
520			_aCONCLUSIONS: Transradial access resulted in a <1% rate of RAO. Copyright (c) 2021 SIR. Published by Elsevier Inc. All rights reserved.
520			_aMATERIALS AND METHODS: Seventy-seven patients undergoing transradial access from August 2019 to March 2021 for 120 intra-arterial procedures (yttrium-90 mapping [n = 39] and radioembolization [n = 38], uterine artery embolization [n = 19], transarterial chemoembolization [n = 10], active bleed embolization [n = 8], angiomyolipoma embolization [n = 4], and other [n = 2]) were enrolled. The average patient age was 59 years +/- 13.1 (range, 30-90 years), and 43 (55.8%) of the 77 patients were men. The patients underwent radial artery (RA) palpation, ultrasound evaluation, the Barbeau test, and the reverse Barbeau test prior to and following the intervention. Verapamil, nitroglycerin, and heparin were administered in a total of 114 (95%) of the 120 procedures prior to starting the procedure. The incidence of RAO and radial artery spasm (RAS) was calculated, and univariate logistic regression was performed to analyze the predictors of RAS.
520			_aPURPOSE: To prospectively determine the rate of radial artery occlusion (RAO) in patients undergoing transradial access for intra-arterial interventions.
520			_aRESULTS: The preprocedural RA diameter (3.0 mm +/- 0.67) was not significantly different from the postprocedural RA diameter (3.0 mm +/- 0.65, P = .904). The RAO rate was determined to be 0.8% (1/120), and this artery recanalized within 1 week. Due to the small number of occlusions, statistical analysis of predictors of RAO was not performed. The rate of RAS was 22.7% (27/119). None of the variables tested-including age, sex, RA diameter, initial versus repeat access, operator experience, and artery puncture technique-showed significant prediction for RAS. Patients were seen for follow-up after 111 (92.5%) of the 120 procedures.
546			_aEnglish
650			_a*Arterial Occlusive Diseases
650			_a*Carcinoma, Hepatocellular
650			_a*Chemoembolization, Therapeutic
650			_a*Liver Neoplasms
650			_aAdult
650			_aAged
650			_aAged, 80 and over
650			_aArterial Occlusive Diseases/dg [Diagnostic Imaging]
650			_aArterial Occlusive Diseases/et [Etiology]
650			_aArterial Occlusive Diseases/th [Therapy]
650			_aCarcinoma, Hepatocellular/co [Complications]
650			_aCardiac Catheterization/ae [Adverse Effects]
650			_aCardiac Catheterization/mt [Methods]
650			_aChemoembolization, Therapeutic/ae [Adverse Effects]
650			_aHumans
650			_aLiver Neoplasms/co [Complications]
650			_aMale
650			_aMiddle Aged
650			_aProspective Studies
650			_aRadial Artery/dg [Diagnostic Imaging]
651			_aMedStar Medical Group
651			_aMedStar Washington Hospital Center
656			_aInternal Medicine Residency
656			_aRadiology
657			_aJournal Article
700			_aHorton, Keith
700			_aRestrepo, Clark R
700			_aSabri, Saher S
700			_aSivananthan, Gajan
700			_aTabori, Nora E
790			_aHorton KM, Restrepo CR, Sabri SS, Sivananthan G, Tabori NE
856			_uhttps://dx.doi.org/10.1016/j.jvir.2021.10.017 _zhttps://dx.doi.org/10.1016/j.jvir.2021.10.017
942			_cART _dArticle
999			_c985 _d985